HCPCS Level IIdrugActive
J3470
Hyaluronidase injection
BETOS: O1E
Effective: 1997-01-01
Referenced in 2 policies
Description
Injection, hyaluronidase, up to 150 units
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Amphadase
Manufacturer
Amphastar Pharmaceuticals, Inc.
HCPCS Dosage
150 UNITS
Billing Units
1.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.